CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Nektar Therapeutics Grants 45,750 Stock Options, 2,775 RSUs to 16 New Employees

By Public Technologies
  • Nektar Therapeutics granted 45,750 non-qualified stock options and 2,775 restricted stock units on October 20, 2026.
  • The awards cover 16 newly hired employees under the 2025 Inducement Plan, with vesting conditional on continued employment.
  • A September 23, 2026 amendment increased shares available under the plan by 250,000 to 500,000.
  • Options have eight-year terms, vesting 25% on the first grant anniversary, then 1/48 monthly over the next three years.
  • Restricted stock units vest 25% following the first grant anniversary, then 1/16 quarterly over the next three years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nektar Therapeutics published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610231615PR_NEWS_USPR_____SF79946) on October 23, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.